WallStreetZenWallStreetZen

NASDAQ: BRKR
Bruker Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bruker earnings were $79.6M for the trailing 12 months ending Jun 30, 2025, with -78.4% growth year over year. The latest BRKR earnings report on Jun 30, 2025 announced Q2 2025 earnings of $7.6M, down 56.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BRKR reported annual earnings of $113.1M, with -73.5% growth. The next BRKR earnings date is Nov 4, 2025.

BRKR past earnings growth

How has BRKR's earnings growth performed historically?

Company
-78.42%
Industry
83.98%
Market
34.43%
BRKR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BRKR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BRKR's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BRKR earnings history

Current Revenue
$3.4B
Current Earnings
$79.6M
Current Profit Margin
2.3%
BRKR's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BRKR Return on Equity

Current Company
4.4%
Current Industry
15.2%
Current Market
30.7%
BRKR's Return on Equity (4.4%)... subscribe to Premium to read more.
High Return on Equity Performance

BRKR undefined

Current Company
1.3%
Current Industry
8.9%
BRKR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BRKR announces earnings.

BRKR undefined

Current Company
2.82%
Current Industry
10.6%
BRKR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BRKR vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BRKR$351.10M$79.60M-13.44%$0.52
GKOS-$47.80M-$92.79MN/A-$1.64
TMDX$113.85M$71.66M+2,562.50%$2.13
IRTC-$52.28M-$92.43MN/A-$2.93
ITGR$295.76M$82.66M+1.65%$2.42
View Top Medical Device Stocks

BRKR earnings dates

Next earnings date
Nov 4, 2025

Bruker Earnings Reports & History FAQ

What were Bruker's earnings last quarter?

On BRKR's earnings call on Invalid Date, Bruker (NASDAQ: BRKR) reported Q2 2025 earnings per share (EPS) of $0.05, up 0% year over year. Total BRKR earnings for the quarter were $7.60 million. In the same quarter last year, Bruker's earnings per share (EPS) was $0.05.

If you're new to stock investing, here's how to buy Bruker stock.

When does Bruker report earnings?

The next BRKR earnings call is Invalid Date. Add BRKR to your watchlist to be reminded of Bruker's next earnings date.

Is Bruker profitable or losing money?

As of the last Bruker earnings report, Bruker is currently profitable. Bruker's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $79.60 million, a 77.39% decrease year over year.

What was BRKR's earnings growth in the past year?

As of Bruker's earnings date in Invalid Date, Bruker's earnings has grown -78.42% year over year. This is 162.4 percentage points lower than the US Medical Devices industry earnings growth rate of 83.98%. BRKR earnings in the past year totalled $79.60 million.

What are Bruker's earnings expectations?

The current EPS estimate for Bruker's earnings report in Invalid Date is $0.33.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.